arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Social Sciences · Sociology and Political Science

NOTES Analysis of Antibody Response in Humans to the Type A OspC Loop 5 Domain and Assessment of the Potential Utility of the Loop 5 Epitope in Lyme Disease Vaccine Development

Eric L. Buckles, Christopher G. Earnhart, Richard T. Marconi

See on the map

Abstract

The OspC protein of Borrelia burgdorferi is an immunodominant antigen. Here we demonstrate that the loop 5 domain of type A OspC is surface exposed, elicits bactericidal antibody in mice, and is antigenic in humans. The data suggest that loop 5 may be suitable for inclusion in a polyvalent, chimeric OspC vaccinogen. Outer surface protein C (OspC) of the Lyme disease spiro-chetes is a 22-kDa immunodominant (10) antigen that is ex-pressed upon tick feeding and during early stages of infection (27). Although a strong antibody response to OspC is mounted during natural infection, the response does not lead to bacte-rial clearance because OspC production is turned off shortly after the establishment of infection (27). OspC has emerged as an important virulence factor and a potential candidate for Lyme disease vaccine development. However, efforts to de-velop an OspC-based vaccine have been hampered by its het-erogeneity among strains (29, 32, 33). Although vaccination with OspC elicits a highly protective response, most studies

More like this